Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities
Net loss	$ (10,886,809)	$ (5,707,427)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,151,691	1,055,103
Milestone expense	5,000,000
Accrued interest	53,442
Change in operating assets and liabilities:
Prepaid expenses and other assets	261,552	(345,975)
Accounts payable and other current liabilities	(498,379)	383,896
Net cash used in operating activities	(4,918,503)	(4,614,403)
Financing activities
Proceeds from issuance of common stock, net	3,309,116	5,800,201
Proceeds from issuance of common stock from employee stock purchase plan	119,415
Proceeds from issuance of common stock from stock option exercised	2,627
Proceeds from paycheck protection program	104,168
Proceeds from Eversana line of credit	2,000,000
Net cash provided by financing activities	5,535,326	5,800,201
Net increase in cash and cash equivalents	616,823	1,185,798
Cash and cash equivalents at beginning of period	5,663,833	5,319,004
Cash and cash equivalents at end of period	$ 6,280,656	$ 6,504,802